Transit Dosimetry of Stereotactic Body Radiotherapy Treatments with Electronic Portal Dosimetry Device in Patient with Spinal Implant

Abstract Aim In recent years, the use of the Electronic Portal Imaging Device (EPID) as an in vivo dosimeter has become widespread. However, reports of EPID for stereotactic body radiotherapy (SBRT) applications is scarce. There is no data on this topic especially when there are high-density materials in the radiation field. In this study, we aimed to investigate the dose distributions of SBRT treatment plans in patients with spinal implants by in vivo EPID dosimetry. Material Methods: Implants were inserted in phantoms that mimic the vertebrae, and VMAT plans were created on the phantoms to deliver 16 Gy radiation doses to the target in 1 fraction. In vivo EPID measurements were performed for each irradiation. The results were compared with the treatment planning system using the gamma analysis method. Results According to the gamma analysis results, while the non-implant model met the acceptance criteria with a rate of 95.4%, the implanted models did not pass the test with results between the rates of 70–73%. In addition, while the dose difference in the isocenter was 1.3% for the non-implanted model, this difference was observed to be between 7% and 8% in the implanted models. Conclusion Our study revealed that EPID can be used as in vivo dosimetry for the VMAT-SBRT applications. However, unacceptable dose differences were obtained by in vivo EPID dosimetry in the VMAT-SBRT applications of patients with an implant. In the treatment of such patients, alternative treatment methods should be preferred in which the interaction of the implants with radiation can be prevented.